I’m lucky, and I know it. In 1984, I was treated for testicular cancer with a then-revolutionary new cocktail of medications known as PVB (the platinum-based drug cisplatin plus vinblastine and bleomycin). Only a few years earlier, close to 100 percent of those diagnosed with “my” kind of cancer died, most of them young men between the ages of 15 and 35. PVB flipped the odds, and after five years, I was deemed cured.